HOW DO PHYSICIANS WEIGH IATROGENIC COMPLICATIONS

被引:32
作者
COHEN, BJ [1 ]
PAUKER, SG [1 ]
机构
[1] TUFTS UNIV,NEW ENGLAND MED CTR,SCH MED,DEPT MED,DIV CLIN DECIS MAKING,BOSTON,MA 02111
关键词
IATROGENIC COMPLICATIONS; MEDICAL DECISION MAKING; PHYSICIANS;
D O I
10.1007/BF02599137
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: To determine how physicians weigh iatrogenic complications when making clinical decisions. Design: Physicians were mailed a questionnaire describing two simplified scenarios-one involving a patient with a cerebral embolism and the other involving a patient with a life-threatening arrhythmia. In each scenario there was one potential natural adverse outcome (which could be prevented with drug therapy) and one potential drug side effect (iatrogenic adverse outcome), which would be clinically indistinguishable from the natural adverse outcome. Half the respondents were given the probability of the natural adverse outcome (P-N) and were asked to specify the probability of the iatrogenic adverse outcome (P-1) at which they felt that giving and withholding the therapy were equivalent strategies. The other respondents were given the P-1 and asked to specify the P-N at which they felt the two strategies were equivalent. Setting: Academic medical center. Participants: Staff physicians. Measurements and main results: Results are expressed as the ratio P-1/P-N at which the respondent felt that giving and not giving therapy were equivalent strategies. A ratio less than 1 indicates that errors of commission (iatrogenic adverse outcomes) were given more weight than were errors of omission (natural adverse outcomes when therapy was withheld). Ratios less than 1 were provided in 56% of the responses (n = 230). The mean P-1/P-N in the group with ratios less than 1 was O.53+/-O.26 (SD; n = 129). Conclusions: In making decisions. some physicians appear to weight errors of commission more heavily than they do errors of omission, while others weigh them equally. This diversity of physicians' attitudes may explain some of the variation observed in clinical practice in settings where the possibility Of iatrogenic complications is of concern.
引用
收藏
页码:20 / 23
页数:4
相关论文
共 8 条
  • [1] Elstein A.S., Holzman G.B., Ravitch M.M., Et al., Comparison of physicians’ decisions regarding estrogen replacement therapy for menopausal women and decisions derived from a decision analytic model, Am J Med, 80, pp. 246-58, (1986)
  • [2] Farquhar P.H., Utility assessment methods, Management Sci, 30, pp. 1283-300, (1984)
  • [3] McNeil B.J., Pauker S.G., Sox H.C., Tversky A., On the elicitation of preferences for alternative therapies, New England Journal of Medicine, 306, pp. 1259-62, (1982)
  • [4] Tversky A., Kahneman D., The framing of decisions and the psychology of choice, Science, 211, pp. 453-8, (1981)
  • [5] Bell D.E., Regret in decision making under uncertainty, Oper Res, 30, pp. 961-81, (1982)
  • [6] Feinstein A.R., The “chagrin factor” and qualitative decision analysis, Arch Intern Med, 145, pp. 1257-9, (1985)
  • [7] Spranca M., Minsk E., Baron J., Omission and commission in judgment and choice, J Exp Soc Psychol, 27, pp. 76-105, (1991)
  • [8] Hershey J.C., Baron J., Clinical reasoning and cognitive processes, Med Decis Making, 7, pp. 203-11, (1987)